6505--760_Pharmaceuticals_VA CMOP Leavenworth_36C77024Q0363
ID: 36C77024Q0363Type: Presolicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNATIONAL CMOP OFFICE (36C770)LEAVENWORTH, KS, 66048, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Set Aside

Total Small Business Set-Aside (FAR 19.5) (SBA)
Timeline
    Description

    Presolicitation VETERANS AFFAIRS, DEPARTMENT OF is seeking a Total Small Business Set-Aside for the procurement of miscellaneous Pharmaceuticals. The Pharmaceuticals are intended for delivery to the CMOP facility in Leavenworth, KS 66048-5580. The items include Timolol Maleate 0.25% Oph Soln, Timolol Maleate 0.5% Oph Soln, Torsemide 10mg Tab, Trandolapril 4mg Tab, Temozolomide 100mg Cap, and Temozolomide 14omg Cap. The quantities range from 216 to 8000 per item. The delivery timeframe is 10 days ARO. The solicitation will be posted on Contract Opportunities (sam.gov). Submit quotes to Jeffrey.Blackard@va.gov.

    Point(s) of Contact
    Blackard, Jeffrey A.TCF Intern
    (913) 684-0142
    Jeffrey.Blackard@va.gov
    Similar Opportunities
    6505--770-24-4-801-0687 - National CMOP BUDESONIDE (VA-24-00098402)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to supply Budesonide 0.5MG/2ML Inhalation Suspension for delivery to multiple Consolidated Mail Outpatient Pharmacy (CMOP) locations. The procurement, identified by solicitation number 36C77024Q0387, requires vendors to provide specific quantities of the pharmaceutical product, adhering to safety and shipping regulations, including compliance with the Drug Supply Chain Security Act. This contract is critical for ensuring the availability of essential medications within the federal healthcare system, with proposals due by September 11, 2024, and an estimated issuance date for the request for quotes on September 6, 2024. Interested vendors must submit their proposals, including a signed SF1449 cover page, a price schedule, a valid state wholesale distributor license, and a Trade Agreements Act certificate, to Contract Specialist Kelley Cunningham at kelley.cunningham@va.gov.
    6505--Zolmitriptan Tablets (VA-25-00006129)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is initiating a Request for Proposal (RFP 36E79724R0028) for the procurement of Zolmitriptan Tablets, aimed at ensuring a reliable supply for various federal health entities, including the Department of Defense and the Bureau of Prisons. The procurement seeks to secure an uninterrupted source of Zolmitriptan, with estimated annual requirements of 28,339 blister packs of 2.5mg tablets and 147,600 blister packs of 5mg tablets, reflecting the critical need for this medication in treating migraines among veterans and other federal beneficiaries. The solicitation is expected to be issued electronically on or around September 5, 2024, with a submission deadline of September 19, 2024; interested vendors should contact Contract Specialist Kenneth Lay at Kenneth.Lay@va.gov for inquiries and must have an FDA-assigned NDC number to participate.
    6505--770-24-4-801-0686 -National CMOP CLINDAMYCIN -(VA-24-00096153)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to provide Clindamycin PO4 1% Top Swab for delivery to multiple Compounding Medication Outpatient Pharmacies (CMOP) across the country. This procurement aims to secure approximately 3,584 units of the specified pharmaceutical product, ensuring compliance with federal regulations and the Drug Supply Chain Security Act (DSCSA). The goods are essential for the VA's healthcare services, supporting the treatment of various medical conditions. Interested vendors must submit their quotations by September 6, 2024, including a signed SF1449 cover page, a price schedule, proof of a valid State Wholesale Distributor License, and a Buy American Act Certificate. For further inquiries, vendors can contact Kelley Cunningham at kelley.cunningham@va.gov or call 913-684-0140.
    6505--Abiraterone Acetate Tablets
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) intends to issue a Request for Proposal (RFP) for the procurement of Abiraterone Acetate Tablets, identified by solicitation number 36E79724R0023. This procurement aims to secure a reliable supply of these pharmaceutical products for the VA, Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and other federal healthcare entities, emphasizing the need for uninterrupted supply and compliance with specific labeling and packaging requirements. The estimated annual requirements include 71,997 bottles of 120-count 250mg tablets and 1,102 bottles of 60-count 500mg tablets, with the RFP scheduled for electronic release on approximately September 18, 2024, and a closing date of October 2, 2024. Interested vendors can direct inquiries to Contract Specialist Richard Mahario at Richard.Mahario@va.gov or by phone at 708-786-5247, and must regularly check SAM.gov for updates as no paper copies of the solicitation will be provided.
    6505--Levothyroxine Tablets (VA-24-00084562)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) intends to solicit proposals for the procurement of Levothyroxine Sodium Tablets under Request for Proposal (RFP) 36E79724R0020. This procurement aims to secure an uninterrupted supply of these essential medications for various VA facilities, including Consolidated Mail Order Pharmacies, State Veterans Homes, the Indian Health Service, and the Federal Health Care Center. The contract will span one year, with the possibility of four additional pre-priced option periods, reflecting the VA's commitment to meeting the pharmaceutical needs of veterans. Interested suppliers must submit their proposals by September 30, 2024, and can direct inquiries to Contract Specialist Youlanda Duggar at Youlanda.duggar@va.gov or by phone at 708-786-4943.
    7510--PRINTER SUPPLIES
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is issuing a presolicitation notice for the procurement of printer supplies, specifically set aside for Service-Disabled Veteran-Owned Small Businesses (SDVOSB). The primary objective is to deliver these items to the Shawnee Consolidated Mail Outpatient Pharmacy (CMOP) in Kansas, with the solicitation number 36C77024Q0379. This procurement falls under Product Service Code 7510 and NAICS code 325992, highlighting the importance of these supplies in supporting the operational needs of the Veterans Affairs network. Quotes are due by September 17, 2024, at 5 PM Central Time, with the solicitation package expected to be available on Sam.gov around September 9, 2024. Interested vendors should submit their quotes via email to Contract Specialist Brigitte Kidder at Brigitte.Kidder@va.gov and are responsible for monitoring the site for any updates or amendments.
    760-24-3-050-0971 -Leavenworth CMOP 1 Line Med/Surg Requirement
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting quotes for the procurement of OneTouch Delica Plus 33G lancets as part of the Leavenworth CMOP 1 Line Med/Surg Requirement. This procurement, categorized as a firm-fixed-price contract, emphasizes the need for specific medical supplies that have been prescribed by VA physicians, ensuring compliance with established Pharmacy Benefits Management guidelines. The total estimated value of this contract is not to exceed $250,000, with a critical delivery timeframe requiring the first shipment within ten days after receipt of order. Interested vendors must submit their quotes, including a signed SF1449 cover page and necessary certifications, by September 11, 2024, at 4:00 PM CST, and can direct inquiries to Sarah Fry at sarah.fry2@va.gov or by phone at 913-758-9935.
    Telmisartan Tablets
    Active
    Dept Of Defense
    Presolicitation DEPT OF DEFENSE is planning to issue a national requirements contract for Telmisartan Tablets. Telmisartan Tablets are pharmaceutical preparations used to treat high blood pressure and reduce the risk of heart attack, stroke, and kidney problems in certain patients. The tablets will be available in 20MG, 40MG, and 80MG strengths, packaged in 30 count bottles. This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. The contract aims to establish a national supply source to provide Telmisartan Tablets to Department of Defense, Bureau of Prisons, Indian Health Service, and Department of Veterans Affairs customers through the DLA and VA prime vendor programs. Interested parties can contact Courtney Hunter-Stangler at (215) 737-6845 or Courtney.Hunter-Stangler@dla.mil for any questions/comments. The solicitation is projected to be issued in August of 2024.
    6505--Prasugrel HCL 5mg and 10mg 30 Count Bottles
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Prasugrel HCL tablets in 5mg and 10mg 30-count bottles, aimed at ensuring a reliable supply for various federal health entities, including the Department of Defense (DoD) and the Bureau of Prisons (BOP). The contract will cover a period of one year with four optional one-year extensions, requiring suppliers to provide products with unique National Drug Codes (NDC) and specific packaging that includes safety caps and designated bottle dimensions. This procurement is critical for maintaining uninterrupted access to essential medications for veterans and other federal health care facilities. Interested vendors should note that the RFP is anticipated to be issued around September 17, 2024, with offers due by October 1, 2024; inquiries should be directed to Contract Specialist Matthew Poulin at Matthew.Poulin@va.gov.
    Valsartan
    Active
    Dept Of Defense
    Presolicitation DEPT OF DEFENSE is planning to issue a national requirements contract for Valsartan, a drug used for treating high blood pressure and heart failure. The contract will include Valsartan tablets in various strengths and quantities. It will be a firm-fixed price, requirements type contract with a one year base and four one year options. The contract aims to establish a national supply source for Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers. Interested parties can contact Catherine Gilbert for more information. The solicitation is projected to be issued in December 2019.